Respiratory Disease Testing Global Market Report 2025
상품코드:1824308
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 호흡기 질환 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 5.5%로 확대되어 46억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 공기감염 호흡기 바이러스 증가, 재택검사 솔루션에 대한 주목, 정밀의료에서의 조사 증가, 지속적인 환경위생에 대한 우려, 조기 개입과 예방에 대한 주목 등에 기인하고 있습니다. 예측 기간의 주요 동향으로는 포인트 오브 케어 검사, 인공지능(AI) 통합, 원격 모니터링 기술, 원격 의료 서비스, 맞춤형 바이오마커 패널, 호기 분석 기술 강화 등이 있습니다.
향후 5년간의 성장률 5.5%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세장벽은 이탈리아와 이스라엘에서 조달하는 폐활량 측정 센서와 호기 일산화질소 분석기의 비용을 상승시킴으로써 미국의 진단실을 저해하고, 폐기능 평가를 늦추고 호흡 케어 지출을 상승시킬 것으로 예측됩니다. 이 효과는 또한 상호관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 부정적인 영향으로 더욱 광범위하게 작용할 수 있습니다.
호흡기 질환의 유병률은 상승 경향에 있으며, 호흡기 질환 검사 시장을 크게 밀어 올릴 것으로 예측됩니다. 호흡기 질환은 폐, 기관지, 기관, 후두, 인두, 비강 등의 호흡기 시스템에 영향을 미치는 병리학을 포함합니다. 호흡기 질환 검사의 주요 목적은 조기 발견과 진단, 신속한 치료 및 관리입니다. 이 적극적인 접근법은 질병의 진행을 방해할 뿐만 아니라 감염성 호흡기 질환의 감염을 억제하고 합병증의 위험을 줄이는 데에도 매우 중요합니다. 예를 들어, 2022년 9월에 NCD Alliance가 발표한 데이터에 따르면 폐암은 세계 암 사망 원인의 1위이며 연간 220만명이 새로 고통받고 180만명이 사망할 것으로 예측되고 있습니다. 만성 호흡기 질환은 전 세계 5억 5,000만 명의 성인을 앓고 있으며, 420만 명이 사망하여 전체의 7%를 차지합니다. 따라서 호흡기 질환의 유병률 증가는 호흡기 질환 검사 시장의 주요 촉진요인입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 호흡기 질환 검사 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 호흡기 질환 검사 시장 : 성장률 분석
세계의 호흡기 질환 검사 시장 실적 : 규모와 성장, 2019-2024년
세계의 호흡기 질환 검사 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 호흡기 질환 검사 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 호흡기 질환 검사 시장 : 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
영상 검사
기계 검사
체외 진단 검사
세계의 호흡기 질환 검사 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
폐용량
영상
폐활량 측정
피크 플로우
혈액가스
기타
세계의 호흡기 질환 검사 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
만성 폐색성 폐질환
폐암
천식
결핵 여성
기타
세계의 호흡기 질환 검사 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
의사 클리닉
임상 실험실
기타
세계의 호흡기 질환 검사 시장 : 영상 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
X선
컴퓨터 단층 촬영(CT) 스캔
자기 공명 영상법(MRI)
양전자 방출 단층 촬영(PET) 스캔
세계의 호흡기 질환 검사 시장 : 기계 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
폐활량 측정
피크 플로우 측정
폐용량 측정
확산 능력 검사
세계의 호흡기 질환 검사 시장 : 체외 진단 검사별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
PCR 검사
항원 검사
항체 검사
배양 검사
제7장 지역별/국가별 분석
세계의 호흡기 질환 검사 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 호흡기 질환 검사 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
호흡기 질환 검사 시장 : 경쟁 구도
호흡기 질환 검사 시장 : 기업 프로파일
Medtronic plc
Abbott Laboratories
Siemens Healthineers AG
Koninklijke Philips NV
ResMed Inc.
제31장 기타 주요 기업 및 혁신 기업
Thermo Fisher Scientific Inc.
Becton Dickinson and Company
F. Hoffmann-La Roche Ltd.
Nihon Kohden Corporation
GE HealthCare Technologies Inc.
Fisher & Paykel Healthcare Corporation Limited
Qiagen NV
Medical Graphics Corporation
COSMED srl
ndd Medizintechnik AG
Vitalograph Ltd.
MGC Diagnostics Corporation
Vyaire Medical Inc.
Masimo Corporation
Hamilton Medical AG
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
호흡기 질환 검사 시장(2029년) : 새로운 기회를 제공하는 국가
호흡기 질환 검사 시장(2029년) : 새로운 기회를 제공하는 부문
호흡기 질환 검사 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.
The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory disease testing market size has grown steadily in recent years. It will grow from $3.6 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to environmental factors and pollution, tobacco smoking epidemic, occupational respiratory hazards, awareness and health education programs, government initiatives for disease control.
The respiratory disease testing market size is expected to see strong growth in the next few years. It will grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in airborne respiratory viruses, focus on home-based testing solutions, increased research in precision medicine, continued environmental health concerns, focus on early intervention and prevention. Major trends in the forecast period include point-of-care testing, integration of artificial intelligence (AI), remote monitoring technologies, telehealth services, customized biomarker panels, enhanced breath analysis techniques.
The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. diagnostic labs by increasing the cost of spirometry sensors and exhaled nitric oxide analyzers sourced from Italy and Israel, thereby slowing pulmonary function assessments and elevating respiratory care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.
The increasing prevalence of tobacco smoking is anticipated to boost the growth of the respiratory disease testing market in the future. Tobacco smoking involves the combustion of dried leaves from the tobacco plant (Nicotiana tabacum) and inhaling the smoke produced. Respiratory disease testing is essential for managing the health of tobacco smokers, as it monitors changes in lung function over time, enabling healthcare professionals to evaluate the success of smoking cessation initiatives and modify treatment plans accordingly. For instance, in September 2024, the Centers for Disease Control and Prevention, a US government agency, reported that tobacco use remains the leading cause of preventable illness and death in the United States. In 2022, around 49.2 million adults, or 19.8%-nearly 1 in 5-indicated they used tobacco products. Consequently, the rising incidence of tobacco smoking is driving the expansion of the respiratory disease testing market.
Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.
Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.
In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.
Major companies operating in the respiratory disease testing market include Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc., Natus Medical Incorporated
North America was the largest region in the respiratory disease testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Disease Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for respiratory disease testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory disease testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
Subsegments:
1) By Imaging Tests: X-rays; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans
3. Respiratory Disease Testing Market Trends And Strategies
4. Respiratory Disease Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Respiratory Disease Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Respiratory Disease Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Respiratory Disease Testing Market Growth Rate Analysis
5.4. Global Respiratory Disease Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Respiratory Disease Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Respiratory Disease Testing Total Addressable Market (TAM)
6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging Tests
Mechanical Tests
In-Vitro Diagnostic Tests
6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Volume
Imaging
Spirometry
Peak Flow
Blood Gas
Other Products
6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Obstructive Pulmonary Disease
Lung Cancer
Asthma
Tuberculosis Female
Other Application
6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Physician clinics
Clinical laboratories
Other End-User
6.5. Global Respiratory Disease Testing Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
X-rays
Computed Tomography (CT) Scans
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET) Scans
6.6. Global Respiratory Disease Testing Market, Sub-Segmentation Of Mechanical Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Spirometry
Peak Flow Measurement
Lung Volume Measurement
Diffusion Capacity Tests
6.7. Global Respiratory Disease Testing Market, Sub-Segmentation Of In-Vitro Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR Tests
Antigen Tests
Antibody Tests
Culture Tests
7. Respiratory Disease Testing Market Regional And Country Analysis
7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
